| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |